ClinicalTrials.Veeva

Menu

Efficacy Comparative Study Between Tears Again®, Opticol® and Optive®

H

Hospital de Sao Sebastiao

Status

Completed

Conditions

Dry Eye Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT00893243
HSS-01-08

Details and patient eligibility

About

Primary Purpose:

  • To compare the efficacy in treating dry eye syndrome in contact lens wearers or computer users of Tears Again® versus Opticol® versus Optive®

Secondary Purpose:

  • Subjective evaluation of symptomatology
  • Evaluation of preference in different kind of administration - spray versus monodoses versus multi-doses

Enrollment

27 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Informed Consent signed
  • Age >18 years and < 55 years
  • Daily wearer of soft contact lens and/or daily (> 4 hours/day) computer user

Exclusion criteria

  • Dry eye Syndrome other than of evaporative etiology, according to DEWS
  • Ocular or systemic disease that can affect the normal tear film
  • Pregnancy or pregnancy risk (no contraceptive method), lactation

Trial design

27 participants in 6 patient groups

1Tears Again/Control
2Opticol/Control
3Optive/Control
4Tears Again/Opticol
5Tears Again/Optive
6Opticol/Optive

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems